JUBILANT PHARMOVA Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA Quarterly Results    (JUBOL)

Here are the latest quarterly results of JUBILANT PHARMOVA . For more details, see the JUBILANT PHARMOVA financial fact sheet and JUBILANT PHARMOVA share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

JUBILANT PHARMOVA Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
3
Jun-21
*
3
Sep-21
*
3
Dec-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m23,91411,56123,74917,71315,79816,34716,57513,105 
Other income Rs m19439733667394559 
Turnover Rs m24,10911,60023,82217,74915,86516,38516,61913,164 
Expenses Rs m18,5489,76818,88712,78612,05212,59413,18011,163 
Gross profit Rs m5,3661,7934,8624,8193,6433,7523,3951,942 
Depreciation Rs m1,2898171,158959862880998933 
Interest Rs m712479640464433346347366 
Profit before tax Rs m3,5605363,1373,4322,4142,5652,094702 
Tax Rs m9551828961,212831860654194 
Profit after tax Rs m2,6053542,2412,2201,5831,7051,440508 
Gross profit margin %22.415.520.527.223.123.020.514.8 
Effective tax rate %26.834.028.535.334.433.531.227.7 
Net profit margin %10.93.19.412.510.010.48.73.9 
Diluted EPS Rs 16.4 2.2 14.1 13.9 9.9 10.7 9.0 3.2  
Diluted EPS (TTM) Rs 56.4 47.0 45.4 46.6 40.2 48.6 43.6 32.9  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Views on news

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


May 23, 2022 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - MYLAN COMPARISON

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS